• Aucun résultat trouvé

CD4+CD25−mTGFβ+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma

N/A
N/A
Protected

Academic year: 2021

Partager "CD4+CD25−mTGFβ+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma"

Copied!
11
0
0

Texte intégral

Figure

Fig. 1. INT with OVA protects against cell recruitment into BALF upon OVA aerosol challenge
Fig. 2. OVA INT protects against re-exposure to OVA aerosol for an extended period of time in an antigen-specific manner and limits bronchial hyperresponsiveness and T-cell proliferation
Fig. 4. OVA INT (1.5 mg) prevents cytokines production in lungs upon allergen challenge
Fig. 5. OVA INT (1.5 mg) prevents cytokines production by BLN and lung cells 3 days after allergen challenge
+3

Références

Documents relatifs